K. Van Malderen

Volatomics in inflammatory bowel disease and irritable bowel syndrome

B. D. De Winter, J. D. De Man, H. D. De Schepper, 2020, EBioMedicine.

Allelic variant in the glucagon‐like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study

A. Zinsmeister, M. Camilleri, A. Zinsmeister, 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid‐naïve patients

M. Camilleri, H. Halawi, K. Van Malderen, 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study

B. D. De Winter, H. Ceuleers, J. D. De Man, 2022, Frontiers in Medicine.

Malignancy and Meckel’s diverticulum: A systematic literature review and 14-year experience at a tertiary referral center

M. Camilleri, D. Larson, R. Cima, 2018, United European gastroenterology journal.

Epidemiological characteristics of a population visiting a patient-centered informative website about irritable bowel syndrome.

H. D. De Schepper, K. Van Malderen, J. De Man, 2023, Acta gastro-enterologica Belgica.